Recent Antiphospholipid Syndrome News:

 

• Rheumatic Diseases and ART Pregnancies: Things to Consider – Medscape
• Evaluation of Apixaban in Patients With Antiphospholipid Syndrome: A Case Series and …
• Immunogenicity, safety, and antiphospholipid antibodies after SARS-CoV-2 vaccine in …
• SAPHO Part 1 – Healio
• The Psychological Impact of COVID-19 on Residents of Saudi Arabia – Docwire News
• Q&A: Non-criteria manifestations of pediatric APS common yet ‘under-recognized’ – Healio
• Does He Have Back Pain or Rheumatism? – Medscape
• Hypercoagulable Treatment Market Comprehensive Study Explores Huge Growth Near in The Future
• Teriflunomide normalizes anti-anxiety effect in anti-ANXA2 APS mice model … – DocWire News
• Are Patients With Triple-Positive Antiphospholipid Syndrome at Higher Risk for Severe COVID-19?
• Rare hematology disorders Market to Witness Massive Growth by Biogen, Bayer, Pfizer
• Antiphospholipid Syndrome Market: Analysis of Epidemiology, Pipeline Products, and Key …
• Algal Protein Market Insights 2022, Global and Chinese Analysis and Forecast to 2027 – Spooool.ie
• ‘Predicting the future’: Emerging technology may help choose right drug at the right time – Healio
• Scrub Typhus and COVID-19 Coinfection Unmasking Antiphospholipid Antibody Syndrome – Cureus
• Sjögren’s syndrome ‘not curable, but certainly treatable’ with available therapies – Healio
• Future of lupus management may require further disease subdivision – Healio
• Pre-eclampsia: Doctors reveal symptoms, causes, diagnosis and treatments | Health
• ‘Oft-neglected’ Sjögren’s syndrome now second most common autoimmune disease – Healio
• Nephritis, phospholipid antibodies contribute to cardiovascular risk in lupus – Healio
• Blind former army soldier Kelly Ganfield to compete at the Veteran Games in Israel | Wiltshire Times
• Thrombocytopenia in primary antiphospholipid syndrome: Association with prognosis and …
• Autoantibody Profiles Shown to Predict Patients at High Risk for SLE – Rheumatology Advisor
• Apixaban Compared With Warfarin for Thrombotic Antiphospholipid Syndrome – Hematology Advisor
• CPD: Key questions on anticoagulation – Pulse Today
• STAR aims to be ‘gold standard’ for outcome measures in Sjögren’s syndrome – Healio
• Latest Antiphospholipid Syndrome (Aps) Market Growth Statistics 2020, Industry Trends …
• Antiphospholipid Antibody Syndrome Market New Report 2027 – ManufactureLink
• The Link Between Frontotemporal Dementia and Autoimmunity: A Case Presentation and … – Cureus
• Primary antiphospholipid syndrome as a cause of impaired left ventricular diastolic function
• Systemic Sclerosis Increases Risk of Adverse Pregnancy Outcomes – Rheumatology Network
• Children with lupus at higher COVID-19 hospitalization risk vs. those with JIA – Healio
• Importance of Pediatric Immunizations – YouTube
• Major determinants of prolonged remission in systemic lupus erythematosus – DocWire News
• Anti-Phospholipid Antibodies Are Elevated & Functionally Active in Chronic Rhinosinusitis …
• Hypercoagulable Treatment Market 2021 Analysis By Growth Rate, Key Drivers, Restraints …
• Catastrophic Anti-Phospholipid Syndrome in Systemic Lupus Erythematosus – DocWire News
• EULAR/ACR: Complex immunodysregulatory diseases require multidisciplinary approach – Healio
• Sjögren’s Foundation shares patient stories for awareness month – Healio
• Search and sequence analysis tools services from EMBL-EBI in 2022 – Docwire News
• Impact of COVID-19 and COVID-19 vaccination on high-risk patients with Antiphospholipid Syndrome
• The Lupus Attack: A Case Report and Literature Review of Myocardial Infarction and … – Cureus
• Miscarriage Testing Market To Grow On A Stellar Note Amidst Innovation – Lake Shore Gazette
• Older children, those with high ferritin at greater risk for severe MIS-C after COVID-19 – Healio
• Antiphospholipid Syndrome in a Patient With Autosomal Dominant Polycystic Kidney Disease
• A Novel Thrombolytic Regimen for Mechanical Prosthetic Valve Thrombosis in a Patient … – Cureus
• Small intestine necrosis in catastrophic antiphospholipid syndrome: A rare and severe case
• Successful rituximab therapy for pediatric antiphospholipid-related chorea: a case report …
• SLE & Antiphospholipid Antibody Syndrome as Risk Factors for Acute … – Physician’s Weekly
• Autoimmune disease and COVID-19- a multicentre observational study in the United Kingdom

Antiphospholipid Syndrome News:

 

• Nine research updates in thrombosis treatment, surveillance and risk prediction.

• Antiphospholipid syndrome. This review summarizes the main knowledge on the clinical and therapeutic aspects of this syndrome.

• Antiphospholipid syndrome: frequency, main causes and risk factors of mortality. Thrombotic complications are the most common cause of death in APS.

• Autoantibodies may be a risk factor for heart attack

• Heart attack: New finding may change the face of treatment

• Hughes syndrome (antiphospholipid syndrome) and the nervous system.

• When autoimmune diseases exert neuro-ophthalmic effects

• Catastrophic antiphospholipid syndrome: The current management approach.

•  2016 review on catastrophic antiphospholipid syndrome.

• Antiphospholipid syndrome in obstetrics.

• Pregnancy and APS: Results Look Encouraging

• The Role of Viral Infections and Vaccines in the Pathogenesis of Antiphospholipid Syndrome

• Anticoagulating patients with high-risk acquired thrombophilias.

• Infectious, Noninfectious Postoperative Complications More Frequent in Patients With SLE

• Catastrophic antiphospholipid syndrome: The current management approach.

• Rapidly progressive coronary artery disease as the first manifestation of antiphospholipid syndrome.  case report
• C-sections raise blood clot risk; protection urged in new recommendation from American College of Obstetricians and Gynecologists. CBS News,
• Myasthenia gravis  is sometimes found in conjunction with antiphospholipid syndrome with: A case report
• Primary antiphospholipid syndrome should be considered as a possible cause of repeated stent thrombosis. Journal of Cardiology Cases.
  
• Good news for prospective mothers with antiphospholipid syndrome? –  Journal of Postgraduate Medicine
• New study suggests that long-term anticoagulation with low molecular weight heparin (LMWH) may be a safe and effective alternative for APS patients who had not responded to warfarin (Coumadin) – Annals of Rhematic Diseases

• Rheumatologist Dr. Doruk Erkan talks about Antiphospholipid Syndrome (APS), the disorder that caused my stroke, in this Q&A with the Hospital for Special Surgery. Read it to learn more about APS. – Dr. Doruk Erkan, Rheumatologist

• Antiphospholipid syndrome plus rheumatic fever: A higher risk factor for stroke? – MD Linx

• Preeclampsia: New Research Reveals Why Preeclampsia More Likely For Some Women – Mattason’s Review

• Antiphospholipid syndrome: endocrinologic manifestations and organ involvement